C146H161F6N25O21 — CID 159018055
6-(2-cyanopropan-2-yl)-N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]pyridazine-4-carboxamide;2-(2-cyanopropan-2-yl)-N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]pyridine-4-carboxamide;6-cyclopropyl-N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]pyridazine-4-carboxamide;N-[5-[6-[(3S,4S)-3-methoxyoxan-4-yl]oxy-5-morpholin-4-yl-3-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]-6-(trifluoromethyl)pyridazine-4-carboxamide (PubChem CID 159018055) has the molecular formula C146H161F6N25O21 and a molecular weight of 2716.04 g/mol. Its IUPAC name is 6-(2-cyanopropan-2-yl)-N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]pyridazine-4-carboxamide;2-(2-cyanopropan-2-yl)-N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]pyridine-4-carboxamide;6-cyclopropyl-N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]pyridazine-4-carboxamide;N-[5-[6-[(3S,4S)-3-methoxyoxan-4-yl]oxy-5-morpholin-4-yl-3-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]-6-(trifluoromethyl)pyridazine-4-carboxamide.
| Compound Name | 6-(2-cyanopropan-2-yl)-N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]pyridazine-4-carboxamide;2-(2-cyanopropan-2-yl)-N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]pyridine-4-carboxamide;6-cyclopropyl-N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]pyridazine-4-carboxamide;N-[5-[6-[(3S,4S)-3-methoxyoxan-4-yl]oxy-5-morpholin-4-yl-3-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]-6-(trifluoromethyl)pyridazine-4-carboxamide |
|---|---|
| PubChem CID | 159018055 |
| Molecular Formula | C146H161F6N25O21 |
| Molecular Weight | 2716.04 g/mol |
| Exact Mass | 2714.22 |
| IUPAC Name | 6-(2-cyanopropan-2-yl)-N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]pyridazine-4-carboxamide;2-(2-cyanopropan-2-yl)-N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]pyridine-4-carboxamide;6-cyclopropyl-N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]pyridazine-4-carboxamide;N-[5-[6-[(3S,4S)-3-methoxyoxan-4-yl]oxy-5-morpholin-4-yl-3-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]-6-(trifluoromethyl)pyridazine-4-carboxamide |
| SMILES | CO[C@H]1COCC[C@@H]1Oc1ncc(-c2cc(NC(=O)c3cccc(C(F)(F)F)c3)cnc2C)cc1N1CCOCC1.Cc1ccc(NC(=O)c2ccnc(C(C)(C)C#N)c2)cc1-c1cc(OC2CCOCC2)nc(N2CCOCC2)c1.Cc1ccc(NC(=O)c2cnnc(C(C)(C)C#N)c2)cc1-c1cc(OC2CCOCC2)nc(N2CCOCC2)c1.Cc1ccc(NC(=O)c2cnnc(C(F)(F)F)c2)cc1-c1cc(OC2CCOCC2)nc(N2CCOCC2)c1.Cc1ccc(NC(=O)c2cnnc(C3CC3)c2)cc1-c1cc(OC2CCOCC2)nc(N2CCOCC2)c1 |
| InChI | InChI=1S/C31H35N5O4.C30H34N6O4.C29H31F3N4O5.C29H33N5O4.C27H28F3N5O4/c1-21-4-5-24(34-30(37)22-6-9-33-27(16-22)31(2,3)20-32)19-26(21)23-17-28(36-10-14-39-15-11-36)35-29(18-23)40-25-7-12-38-13-8-25;1-20-4-5-23(33-29(37)22-14-26(35-32-18-22)30(2,3)19-31)17-25(20)21-15-27(36-8-12-39-13-9-36)34-28(16-21)40-24-6-10-38-11-7-24;1-18-23(14-22(16-33-18)35-27(37)19-4-3-5-21(12-19)29(30,31)32)20-13-24(36-7-10-39-11-8-36)28(34-15-20)41-25-6-9-40-17-26(25)38-2;1-19-2-5-23(31-29(35)22-14-26(20-3-4-20)33-30-18-22)17-25(19)21-15-27(34-8-12-37-13-9-34)32-28(16-21)38-24-6-10-36-11-7-24;1-17-2-3-20(32-26(36)19-12-23(27(28,29)30)34-31-16-19)15-22(17)18-13-24(35-6-10-38-11-7-35)33-25(14-18)39-21-4-8-37-9-5-21/h4-6,9,16-19,25H,7-8,10-15H2,1-3H3,(H,34,37);4-5,14-18,24H,6-13H2,1-3H3,(H,33,37);3-5,12-16,25-26H,6-11,17H2,1-2H3,(H,35,37);2,5,14-18,20,24H,3-4,6-13H2,1H3,(H,31,35);2-3,12-16,21H,4-11H2,1H3,(H,32,36)/t;;25-,26-;;/m..0../s1 |
| InChIKey | JTIJROHEHLEADU-QKTOXZMPSA-N |
| XLogP | 22.82 |
| TPSA | 524.53 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 41 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 198 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2716.04 |
| LogP ≤ 5 | 22.82 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 41 |